Aarkstore.com T cell lymphomas – pipeline review, h1 2012

390 views
371 views

Published on

Aarkstore.com announce a new report "T-Cell Lymphomas – Pipeline Review, H1 2012" through its vast collection of market research report.

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
390
On SlideShare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
3
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Aarkstore.com T cell lymphomas – pipeline review, h1 2012

  1. 1. Aarkstore.com announces, a new market research report is available in its vast collection T-Cell Lymphomas – Pipeline Review, H1 2012 http://www.aarkstore.com/reports/T-Cell-Lymphomas-Pipeline-Review-H1-2012-200360.html RSS FEED: http://www.aarkstore.com/feeds/Global-Markets-Direct.xmlSummary:Global Markets Direct’s, T-Cell Lymphomas - Pipeline Review, H1 2012, provides anoverview of the T-Cell Lymphomas therapeutic pipeline. This report providesinformation on the therapeutic development for T-Cell Lymphomas, complete withlatest updates, and special features on late-stage and discontinued projects. It alsoreviews key players involved in the therapeutic development for T-Cell Lymphomas.Scope:- A snapshot of the global therapeutic scenario for T-Cell Lymphomas.- A review of the T-Cell Lymphomas products under development by companies anduniversities/research institutes based on information derived from company andindustry-specific sources.- Coverage of products based on various stages of development ranging fromdiscovery till registration stages.Reasons to buy:- Identify and understand important and diverse types of therapeutics underdevelopment for T-Cell Lymphomas.- Identify emerging players with potentially strong product portfolio and designeffective counter-strategies to gain competitive advantage.
  2. 2. Table of Contents :List of Tables 5List of Figures 6Introduction 8Global Markets Direct Report Coverage 8T-Cell Lymphomas Overview 9Therapeutics Development 10An Overview of Pipeline Products for T-Cell Lymphomas 10T-Cell Lymphomas Therapeutics under Development by Companies 12T-Cell Lymphomas Therapeutics under Investigation by Universities/Institutes 15Late Stage Products 19Comparative Analysis 19Mid Clinical Stage Products 20List of Tables:Number of Products Under Development for T-Cell Lymphomas, H1 2012 16Products under Development for T-Cell Lymphomas – Comparative Analysis, H12012 17Number of Products under Development by Companies, H1 2012 19Number of Products under Development by Companies, H1 2012 (Contd..1) 20Number of Products under Investigation by Universities/Institutes, H1 2012 22Number of Products under Investigation by Universities/Institutes, H1 2012(Contd..1) 23
  3. 3. More Report:Thymus Cancer – Pipeline Review, H1 2012Vulvar Cancer – Pipeline Review, H1 2012Soft Tissue Sarcoma – Pipeline Review, H1 2012Germ Cell Tumors – Pipeline Review, H1 2012Systemic Juvenile Idiopathic Arthritis (SJIA) – Pipeline Review, H1 2012More Related Reports:T-Cell Lymphomas Global Clinical Trials Review, H1, 2012T-Cell Lymphomas - Pipeline Review, H2 2011T-Cell Lymphomas - Pipeline Review, Q4 2010T-cell Lymphomas Global Clinical Trials Review, Q4, 2010From: Aarkstore EnterpriseContact: Marketing Team(Dipti)Mob.No.918149852585/919272852585Email: enquiry@aarkstore.comURL: http://www.aarkstore.com/http://in.linkedin.com/in/aarkstorehttp://www.facebook.com/aarkstore

×